T-Cell Assays for Tuberculosis Infection: Deriving Cut-Offs for Conversions Using Reproducibility Data
Open Access
- 26 March 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (3) , e1850
- https://doi.org/10.1371/journal.pone.0001850
Abstract
Although interferon-gamma release assays (IGRA) are promising alternatives to the tuberculin skin test, interpretation of repeated testing results is hampered by lack of evidence on optimal cut-offs for conversions and reversions. A logical start is to determine the within-person variability of T-cell responses during serial testing. We performed a pilot study in India, to evaluate the short-term reproducibility of QuantiFERON-TB Gold In Tube assay (QFT) among 14 healthcare workers (HCWs) who underwent 4 serial QFT tests on day 0, 3, 9 and 12. QFT ELISA was repeated twice on the same sets of specimens. We assessed two types of reproducibility: 1) test-retest reproducibility (between-test variability), and 2) within-person reproducibility over time. Test-retest reproducibility: with dichotomous test results, extremely high concordance was noticed between two tests performed on the same sets of specimens: of the 56 samples, the test and re-test results agreed for all but 2 individuals (κ = 0.94). Discordance was noted in subjects who had IFN-γ values around the cut-off point, with both increases and decreases noted. With continuous IFN-γ results, re-test results tended to produce higher estimates of IFN-γ than the original test. Within-person reproducibility: when continuous IFN-γ data were analyzed, the within-person reproducibility was moderate to high. While persons with negative QFT results generally stayed negative, positive results tended to vary over time. Our data showed that increases of more than 16% in the IFN-γ levels are statistically improbable in the short-term. Conservatively assuming that long-term variability might be at least twice higher than short-term, we hypothesize that a QFT conversion requires two conditions to be met: 1) change from negative to positive result, and 2) at least 30% increase in the baseline IFN-γ response. Larger studies are needed to confirm our preliminary findings, and determine the conversion thresholds for IGRAs.Keywords
This publication has 25 references indexed in Scilit:
- Agreement Between Methods of Measurement with Multiple Observations Per IndividualJournal of Biopharmaceutical Statistics, 2007
- Serial Testing for Tuberculosis: Can We Make Sense of T Cell Assay Conversions and Reversions?PLoS Medicine, 2007
- Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis InfectionPLoS Medicine, 2007
- The prognosis of latent tuberculosis: can disease be predicted?Trends in Molecular Medicine, 2007
- Sensitivity of a Whole-Blood Interferon-Gamma Assay Among Patients with Pulmonary Tuberculosis and Variations in T-Cell Responses During Anti-Tuberculosis TreatmentInfection, 2007
- Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural IndiaJournal of Infection, 2007
- Using ELISPOT to Expose False Positive Skin Test Conversion in Tuberculosis ContactsPLOS ONE, 2007
- Nosocomial Tuberculosis in IndiaEmerging Infectious Diseases, 2006
- Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ AssayAmerican Journal of Respiratory and Critical Care Medicine, 2006
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986